---
$id: https://graph.org.ai/products/commodity/51343822
$type: Product
source: UNSPSC
code: "51343822"
title: "Atazanavir/ritonavir"
class: "51343800"
classTitle: "Combination antivirals"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Atazanavir/ritonavir

**UNSPSC Code**: 51343822
**Class**: [Combination antivirals](Combination antivirals.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

Definition: This classification denotes a combination drug for treatment of HIV. The first component, ATAZANAVIR is a protease inhibitor with a US FDA Unique Ingredient Identifier of QZU4H47A3S. ATAZANAVIR is an International Non-Proprietary Name or INN. The second component, RITONAVIR, is a pharmacokinetic booster with a US FDA Unique Ingredient Identifier of O3J8G9O825. RITONAVIR is an International Non-Proprietary Name or INN.

